lipopolysaccharide (Salmo~ella t~,phi lipopolysaccharide W, Difco Laboratories, Detroit, MI), as described previously (13) . BALB/c mice were obtained from a stock maintained in the Department of Microbiology and Immunology at the University of Washington. C57BL/KsJ and CBA/J mice were purchased from The Jackson Laboratory (Bar Harbor, ME).
HDL (1.063 < d < 1.21 g/ml) was prepared by sequential ultracentrifugation and the delipidated apoproteins were separated by analytical isoelectric focusing using pH 3.5-10.0 ampholytes (400 /lg protein applied per gel), as described previously (13) . Bands containing apoSAA~ and apoSAA2 were located by reference to opaque areas of companion gels, fixed in a solution of 14.7% trichloroacetic acid and 4% sulfosalicylic acid. The apoproteins were eluted from excised and homogenized gel slices by two successive extractions in ~ I 0 vol of 8 M urea/formic acid, pH 3.0, with overnight mixing by vortex at room temperature. The extracts were then dialyzed in Spectrapor 3 tubing against 0.5% acetic acid and lyophilized. Residual ampholytes were removed by two successive extractions with 0.25 ml of 10% trichloroacetic acid, in which the protein was precipitated by a 10-rain centrifugation at ~13,800 g, with a final precipitation in 0.2 ml of -10°C acetone.
Amyloid protein AA was extracted from amyloidotic livers of C57BL/Ks mice injected with Cm~dida albiccms (14) , from amyloidotic spleens of CBA/J mice subjected to 2-3 wk of daily casein administration (15) , and from mixed amyloidotic tissue (liver, spleen, kidney) of casein-treated C57BL/6J mice (the latter provided by Dr. Z. Ali-Khan, Department of Microbiology and Immunology, McGill University). Samples of tissue were homogenized, extracted, and centrifuged (finally in 6 M urea/0.01 M HCOONa/ HCOOH, pH 3.0) essentially as previously described (14) . The centrifuged urea/formic acid extracts were lyophilized after dialysis in Spectrapor 3 tubing vs. 0.5% CH3COOH. Protein AA was isolated from the lyophilized products by Sephadex G-100 chromatography in the urea/formic acid buffer (14) . In another approach, crude protein AA was extracted from the washed and homogenized tissues by sonication and boiling in 7.5% sodium dodecyl sulfate (SDS); protein AA was purified by elution (16) following SDS/ urea polyacrylamide gel electrophoresis (PAGE) (16) of the crude extract.
A~mlysis. SDS/urea PAGE was performed as described elsewhere (13) .
N H2-terminal amino acid sequences were determined with a Beckman sequencer (Model 890C) as described previously (17) .
Results and Discussion and purified amyioid proteins (c-e). By comparison with the apoprotein content of control mouse HDL (a), the HDL obtained from mice 20 b following endotoxin administration is enriched in two polypeptides, apoSAA1 (12.6 kd) and apoSAA2 (11.8 kd) . Lanes c and d show purified apoSAA~ and apoSAAz, respectively, prepared by isoelectric focusing. Lane e shows chromatographically purified murine amyloid protein AA (8.6 kd). Fig. 2 shows the NH2-terminal amino acid sequences of purified murine apoSAAb apoSAA2, and amyloid protein AA obtained from several mouse strains. Each purified apoSAA isotype was observed to be a single polypeptide through 26 NH2-terminal residues, differing from the other isotype in two positions, namely residues 6 and 7. Whereas apoSAA~ contained valine and histidine, respectively, in these positions, the corresponding sequence in apoSAA9 was isoleucine-glycine. This difference was a consistent finding within the three mouse strains (BALB/c, C57BL/KsJ, and CBA/J) examined. A comparison with two previous reports (12, 18) reveals that our findings are consistent with those of Anders et al. (12) , who found both valine and isoleucine at position 6, the presumptive result of analyzing a mixture of apoSAA1 and apoSAA2; at position 7 they found only glycine. Anders et al. (12) also reported that ~35% of their sample, lacking the NH2-terminal pentapeptide, began at isoleucine, a phenomenon that we also encountered in one of three samples of apoSAA2 (from CBA/ J mice). In another study, Gorevic et al. (18) found a mixture of glutamic acid and valine at position 6 in sequences of apoSAA from several mouse strains (including BALB/c), isoleucine with valine at this position in only one instance, and glycine in position 7 in all cases; at other positions they found mixtures of amino acids not observed either by us or by Anders et al. (12) . The failure of previous workers to detect histidine in addition to glycine at position 7 (as expected from samples containing both apoSAAl and apoSAA~) might be explained if, in the earlier studies, only the organic-soluble PTH-amino acid derivatives were examined at this position, leaving the aqueous-soluble histidine-PTH derivative undetected. The unambiguous assignment of a single amino acid sequence to each of the two apoSAA isotypes in the present study clearly identifies them as distinct polypeptides translated from different genes rather than as posttranslationally modified forms of a single precursor. We next examined the amino terminal sequence of protein AA found in amyloid deposits to determine whether it corresponded to one or both serum apoSAA isotypes. The NH2-terminal segments of protein AA from several strains of mice were examined for isotype-specific sequences in positions 6 and 7. The sequences obtained for protein AA isolated from the mixed tissues (liver, spleen, and kidney) of CBA/J mice and C57BL/6J mice, and the previously published sequence of liver protein AA from C57BL/Ks mice (14) are shown in Fig. 2 . In all cases, amyloid protein AA showed NH2-terminal amino acid sequence identity with murine apoSAA2. Sequences corresponding to apoSAAl, i.e., containing the valine-histidine pair in positions 6 and 7, were not detected under conditions that would have identified 5%. Furthermore, we observed differences between amyloid protein AA and apoSAAl at residues 27, 30, and 31 (as shown, Fig. 2) , although a comparison with both serum isotypes was not possible in this region.
In one experiment, protein AA was purified by elution from gel slices after SDS PAGE (16) of proteins obtained by extraction of amyioidotic C57BL/6J tissues in 7.5% SDS, a method that solubilizes >90% of the tissue protein content (J. Hoffman, unpublished observations). Again, the protein AA obtained by this method exclusively contained apoSAA2-type sequences, indicating that these observations do not result from an artifact of our preparative methods. Gorevic et al. (18) originally suggested the possibility that murine amyloid protein AA might be derived from only one of several forms of apoSAA polypeptides. Our present findings show, first, that the two major murine apoSAA isotypes are separate gene products and second, that amyloid protein AA could be derived from only one of of these, namely apoSAA2. Several mechanisms could explain these observations. Differences in the structure of murine apoSAA1 and apoSAA2 may play a role in the selective deposition of apoSAA2-derived protein AA during the pathogenesis of amyloidosis, or both proteins may be initially deposited but broken down at different rates, leading to the selective retention of apoSAA2-derived protein AA. Alternatively, differential gene expression during chronic inflammation could result in the preferential synthesis of apoSAA2 during amyloidogenesis. We note that in addition to the two major isotypes sequenced here we observe trace bands upon isoelectric focusing that may correspond to minor apoSAA isotypes (13) , consistent with the recent report of an mRNA-derived plasmid that encodes a polypeptide having only 71% identity with the NH~-terminal region (residues 8-28) ofmurine amyloid protein AA (19) .
We recently reported the complete 104-amino acid sequence of one fraction of human apoSAA (13) containing two distinct proteins that differ from each other only at positions 52 and 57. The first 20 residues of both are identical with those reported for human protein AA from several laboratories (20) (21) (22) , but amino acids reported for the tissue amyloid proteins at residues 23, 53, 60, 66, 69, 71, and 75 are not in accord with our identifications in the two apoSAA subspecies found (13) . Thus, there appear to be several human allotypes and/or gene loci coding for apoSAA and protein AA. By analogy with our findings using the animal model, the intriguing possibility is suggested that in humans protein AA is derived from a subset of the total complement of apoSAA isotypes. Summary Amyloid protein AA is the presumptive fragment of an acute phase serum apolipoprotein, apoSAA. Two major murine apoSAA isotypes (apoSAAl and apoSAA2) have been identified. The NH~-terminal amino acid sequences of purified murine apoSAA~ and apoSAA2 have been examined and compared with that of murine amyloid protein AA. Our results indicate that apoSAAl and apoSAA2 are separate gene products and that amyloid protein AA has NH2-terminal amino acid sequence identity with only one of these isotypes, namely apoSAA2.
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